Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1940 2
1948 1
1949 1
1950 3
1951 3
1952 3
1953 2
1954 3
1955 4
1956 7
1957 2
1958 2
1959 5
1960 1
1961 4
1962 5
1963 5
1964 12
1965 10
1966 15
1967 8
1968 12
1969 16
1970 16
1971 15
1972 18
1973 20
1974 29
1975 29
1976 40
1977 48
1978 49
1979 47
1980 51
1981 54
1982 32
1983 48
1984 59
1985 53
1986 78
1987 80
1988 82
1989 88
1990 97
1991 101
1992 91
1993 104
1994 88
1995 98
1996 92
1997 96
1998 105
1999 121
2000 109
2001 116
2002 111
2003 121
2004 114
2005 95
2006 123
2007 147
2008 171
2009 152
2010 167
2011 163
2012 149
2013 183
2014 192
2015 194
2016 179
2017 185
2018 227
2019 206
2020 233
2021 232
2022 268
2023 213
2024 162

Text availability

Article attribute

Article type

Publication date

Search Results

5,880 results

Results by year

Filters applied: . Clear all
Page 1
SBRT in Localized Renal Carcinoma: A Review of the Literature.
DE LA Pinta C, Latorre RG, Fuentes R. DE LA Pinta C, et al. Anticancer Res. 2022 Feb;42(2):667-674. doi: 10.21873/anticanres.15525. Anticancer Res. 2022. PMID: 35093865 Review.
The high doses per session might allow the theoretical radioresistance of renal carcinoma to be overcome. SBRT may be a therapeutic alternative in inoperable patients with localized renal carcinoma. ...More research is needed to determine optimal doses …
The high doses per session might allow the theoretical radioresistance of renal carcinoma to be overcome. SBRT may be a therap …
Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.
Li M, Liu G, Jin X, Guo H, Setrerrahmane S, Xu X, Li T, Lin Y, Xu H. Li M, et al. Mol Cancer. 2022 Sep 19;21(1):181. doi: 10.1186/s12943-022-01654-1. Mol Cancer. 2022. PMID: 36117171 Free PMC article.
RESULTS: The analysis of 600 renal carcinoma samples from different sources revealed that the expression level of MIAC is significantly decreased, and corelated with the prognosis and clinical stage of tumors in patients with renal carcinoma. Overexpre …
RESULTS: The analysis of 600 renal carcinoma samples from different sources revealed that the expression level of MIAC is sign …
Renal cell carcinoma: staging and surveillance.
Dunnick NR. Dunnick NR. Abdom Radiol (NY). 2016 Jun;41(6):1079-85. doi: 10.1007/s00261-016-0692-0. Abdom Radiol (NY). 2016. PMID: 26971340 Review.
Early detection, accurate staging, and improved treatment options have resulted in improved 5-year survival of patients with renal carcinoma....
Early detection, accurate staging, and improved treatment options have resulted in improved 5-year survival of patients with renal …
Hereditary Papillary Renal Carcinoma (PDQ): Health Professional Version.
PDQ Cancer Genetics Editorial Board. PDQ Cancer Genetics Editorial Board. 2024 Feb 16. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. 2024 Feb 16. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 33724750 Free Books & Documents. Review.
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the genetics of hereditary papillary renal carcinoma (HPRC). It is intended as a resource to inform and assist clinicians who care fo …
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the gen …
MicroRNA Regulation of TRAIL in Renal Carcinoma: Tiny Juggernauts at Work.
Javed Z, Khan K, Sadia H, Raza S, Sharifi-Rad J, Cho WC. Javed Z, et al. Curr Mol Pharmacol. 2021 Oct 25;14(4):520-526. doi: 10.2174/1874467213999201124124649. Curr Mol Pharmacol. 2021. PMID: 33238861 Review.
Renal Carcinoma (RC) is the ninth most prevalent cancer in men. Advancements in high- throughput technology have begun to scratch the surface of the complex landscape of renal cancer. ...
Renal Carcinoma (RC) is the ninth most prevalent cancer in men. Advancements in high- throughput technology have begun to scra …
Antiangiogenic Therapy in Clear Cell Renal Carcinoma (CCRC): Pharmacological Basis and Clinical Results.
Comandone A, Vana F, Comandone T, Tucci M. Comandone A, et al. Cancers (Basel). 2021 Nov 24;13(23):5896. doi: 10.3390/cancers13235896. Cancers (Basel). 2021. PMID: 34885006 Free PMC article. Review.
As a consequence, many tyrosine kinase inhibitors (TKIs) (sunitinib, sorafenib, pazopanib, axitinib, and cabozantinib), one monoclonal antibody (bevacizumab), and two mammalian target of rapamycin (mTOR) inhibitors (temsirolimus and everolimus) have been investigated and approved …
As a consequence, many tyrosine kinase inhibitors (TKIs) (sunitinib, sorafenib, pazopanib, axitinib, and cabozantinib), one monoclonal antib …
Methylation-related genes involved in renal carcinoma progression.
Zamora-Fuentes JM, Hernández-Lemus E, Espinal-Enríquez J. Zamora-Fuentes JM, et al. Front Genet. 2023 Aug 25;14:1225158. doi: 10.3389/fgene.2023.1225158. eCollection 2023. Front Genet. 2023. PMID: 37693315 Free PMC article.
Understanding the molecular mechanisms driving renal carcinoma progression results crucial for the development of targeted therapies leading to an improvement of patient outcomes. ...Here, we developed a data-driven method to find methylation-related genes, so we co …
Understanding the molecular mechanisms driving renal carcinoma progression results crucial for the development of targeted the …
Curcumin suppresses renal carcinoma tumorigenesis by regulating circ-FNDC3B/miR-138-5p/IGF2 axis.
Xue L, Tao Y, Yuan Y, Qu W, Wang W. Xue L, et al. Anticancer Drugs. 2021 Aug 1;32(7):734-744. doi: 10.1097/CAD.0000000000001063. Anticancer Drugs. 2021. PMID: 34001703
Curcumin has a vital role in the development of renal carcinoma. Nevertheless, the mechanism of curcumin in renal carcinoma tumorigenesis remains largely unknown. Thirty renal carcinoma patients were recruited. Renal carcinoma …
Curcumin has a vital role in the development of renal carcinoma. Nevertheless, the mechanism of curcumin in renal ca …
Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections.
Tripathi SC, Deshmukh V, Creighton CJ, Patil A. Tripathi SC, et al. Front Mol Biosci. 2020 Nov 20;7:579422. doi: 10.3389/fmolb.2020.579422. eCollection 2020. Front Mol Biosci. 2020. PMID: 33330620 Free PMC article.
Our results revealed that TMPRSS2 may not be the co-receptor for coronavirus infection in renal carcinoma patients. The other receptors DPP4, ANPEP, and ENPEP may act as the compensatory receptor proteins to help ACE2. ...Conclusion: Our study indicates that CoV rec …
Our results revealed that TMPRSS2 may not be the co-receptor for coronavirus infection in renal carcinoma patients. The other …
Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies.
Delahunt B. Delahunt B. Pathology. 1999 Aug;31(3):185-90. doi: 10.1080/003130299104945. Pathology. 1999. PMID: 10503259 Review.
Sarcomatoid renal carcinoma (SRC) is an aggressive neoplasm with an age and gender distribution similar to that of conventional (clear cell) renal cell carcinoma (RCC). Genetic and morphologic evidence indicates that the tumor results from de-differentiation of rena …
Sarcomatoid renal carcinoma (SRC) is an aggressive neoplasm with an age and gender distribution similar to that of conventiona …
5,880 results